SCOPUS 정보 검색 플랫폼

Respiratory Care

Volumn 54, Issue 6, 2009, Pages 796-800

Respiratory care and cystic fibrosis

(2) Geller, David E a Rubin, Bruce K b

a NEMOURS CHILDREN S HOSPITAL (United States)

b WAKE FOREST SCHOOL OF MEDICINE (United States)

Author keywords

Cystic fibrosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM; COLISTIN; DENUFOSOL; LANCOVUTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

AEROSOL; BRONCHIECTASIS; CHROMOSOME 7; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; HEMOPTYSIS; HUMAN; INFECTION CONTROL; LUNG CLEARANCE; LUNG FIBROSIS; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NEBULIZER; PATIENT EDUCATION; PATIENT MONITORING; PNEUMOTHORAX; RESPIRATORY CARE; RESPIRATORY FAILURE;

EID: 66849087362 PISSN: 00201324 EISSN: None Source Type: Journal
DOI: 10.4187/002013209790983241 Document Type: Conference Paper

Times cited : (6)

References (14)

1
- 66849109575
- Cystic fibrosis and the respiratory therapist: A 50-year perspective
- discussion 593-594
- Volsko TA. Cystic fibrosis and the respiratory therapist: a 50-year perspective. Respir Care 2009;54(5):587-593; discussion 593-594.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 587-593
- Volsko, T.A.¹

2
- 66849089934
- Cystic fibrosis: Pathogenesis and future treatment strategies
- discussion 603-605
- Ratjen FA. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care 2009;54(5):595-602; discussion 603-605.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 595-602
- Ratjen, F.A.¹

3
- 66849097677
- Mucus, phlegm, and sputum in cystic fibrosis
- discussion 732
- Rubin BK. Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 2009;54(6):726-732; discussion 732.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 726-732
- Rubin, B.K.¹

4
- 66849126372
- Bugs, biofilms, and resistance in cystic fibrosis
- discussion 638-640
- Davies JC, Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009;54(5):628-638; discussion 638-640.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 628-638
- Davies, J.C.¹ Bilton, D.²

5
- 66849138757
- Monitoring respiratory disease severity in cystic fibrosis
- discussion 615-618
- Davies JC, Alton EW. Monitoring respiratory disease severity in cystic fibrosis. Respir Care 2009;54(5):606-615; discussion 615-618.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 606-615
- Davies, J.C.¹ Alton, E.W.²

6
- 66849099545
- Airway-clearance therapy guidelines and implementation
- discussion 751-753
- Lester MK, Flume PA. Airway-clearance therapy guidelines and implementation. Respir Care 2009;54(6):733-750; discussion 751-753.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 733-750
- Lester, M.K.¹ Flume, P.A.²

7
- 66849124547
- Cystic fibrosis pulmonary guidelines: Airway clearance therapies
- Flume PA, Robinson KA, O'Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522-537.
- (2009) Respir Care , vol.54 , Issue.4 , pp. 522-537
- Flume, P.A.¹ Robinson, K.A.² O'Sullivan, B.P.³ Finder, J.D.⁴ Vender, R.L.⁵ Willey-Courand, D.B.⁶ White, T.B.⁷

8
- 66849138758
- Infection control in cystic fibrosis: Cohorting, cross-contamination, and the respiratory therapist
- discussion 656-657
- O'Malley CA. Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist. Respir Care 2009;54(5): 641-655; discussion 656-657.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 641-655
- O'Malley, C.A.¹

9
- 66849142486
- Aerosol antibiotics in cystic fibrosis
- discussion 669-670
- Geller DE. Aerosol antibiotics in cystic fibrosis. Respir Care 2009;54(5):658-669; discussion 669-670.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 658-669
- Geller, D.E.¹

10
- 66849142034
- Respiratory care of the hospitalized patient with cystic fibrosis
- discussion 775-776
- Newton TJ. Respiratory care of the hospitalized patient with cystic fibrosis. Respir Care 2009;54(6):769-775; discussion 775-776.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 769-775
- Newton, T.J.¹

11
- 66849121732
- New aerosol delivery devices for cystic fibrosis
- discussion 767-768
- Kesser KC, Geller DE. New aerosol delivery devices for cystic fibrosis. Respir Care 2009;54(6):754-767; discussion 767-768.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 754-767
- Kesser, K.C.¹ Geller, D.E.²

12
- 66849106907
- Pulmonary complications of cystic fibrosis
- discussion 625-627
- Flume PA. Pulmonary complications of cystic fibrosis. Respir Care 2009;54(5):618-625; discussion 625-627.
- (2009) Respir Care , vol.54 , Issue.5 , pp. 618-625
- Flume, P.A.¹

13
- 66849121733
- Lung transplantation in cystic fibrosis
- discussion 786-787
- Rosenblatt RL. Lung transplantation in cystic fibrosis. Respir Care 2009;54(6):777-786; discussion 786-787.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 777-786
- Rosenblatt, R.L.¹

14
- 66849106400
- Cystic fibrosis foundation: Achieving the mission
- discussion 795
- Marshall BC, Penland CM, Hazle L, Ashlock M, Wetmore D, Campbell PW, Beall RJ. Cystic fibrosis foundation: achieving the mission. Respir Care 2009;54(6):788-795; discussion 795.
- (2009) Respir Care , vol.54 , Issue.6 , pp. 788-795
- Marshall, B.C.¹ Penland, C.M.² Hazle, L.³ Ashlock, M.⁴ Wetmore, D.⁵ Campbell, P.W.⁶ Beall, R.J.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.